A phase II study of YM155, a novel small-molecule suppressor of survivin, in castration-resistant taxane-pretreated prostate cancer
- A. W. Tolcher
- , D. I. Quinn
- , A. Ferrari
- , F. Ahmann
- , G. Giaccone
- , T. Drake
- , A. Keating
- , J. S. De Bono
Research output: Contribution to journal › Article › peer-review
143
Link opens in a new tab
Scopus
citations